Categories LATEST
Advanced Micro Devices (AMD) reports in-line Q3 earnings; stock dips on weaker Q4 outlook
Advanced Micro Devices (NASDAQ: AMD) reported third quarter of 2019 results in which earnings were in line with the market’s estimates. However, revenue missed the targets. The semiconductor giant posted adjusted earnings of $0.18 per share on revenue of $1.80 billion.
Analysts had projected the company to earn $0.18 per share on revenue of $1.81 billion for the third quarter. AMD stock rose about 3% immediately after the earnings announcement in the extended trading session. However, shares of AMD turned to red as the company provided dismal outlook for fourth quarter of 2019.
GAAP net income per share in the recently ended quarter increased to $120 million or $0.11 per share from net income of $102 million or $0.09 per share in the year-ago quarter.
Revenue growth of 9% in the three months ended September 30, 2019, was helped by Computing and Graphics segment revenue growth of 36%, which was primarily driven by increased Ryzen client processor sales.
For the fourth quarter of 2019, AMD expects revenue to be approximately $2.1 billion, plus or minus $50 million, representing an year-over-year increase of 48%. This revenue growth is expected to be driven by an increase in Ryzen, EPYC and Radeon product sales. AMD expects non-GAAP gross margin to be approximately 44% in the fourth quarter of 2019.
“Our first full quarter of 7nm Ryzen, Radeon and EPYC processor sales drove our highest quarterly revenue since 2005, our highest quarterly gross margin since 2012 and a significant increase in net income year-over-year,” said CEO Lisa Su.
AMD stock had rallied 79% so far this year and 96% in the trailing 12 months.
Listen to on-demand earnings calls and hear how management responds to analysts’ questions
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on